ICD-10 Coding for Clotting Disorder(D68.0, D68.32, D68.32B)
Comprehensive guide on ICD-10 coding for clotting disorders, including Factor V Leiden and anticoagulant-related bleeding. Learn about documentation requirements and common coding pitfalls.
Complete code families applicable to Clotting Disorder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D68.51 | Activated protein C resistance | Use when genetic testing confirms Factor V Leiden mutation. |
|
| D68.59 | Other primary thrombophilia | Use for inherited thrombophilias other than Factor V Leiden. |
|
| D68.32 | Hemorrhagic disorder due to extrinsic circulating anticoagulants | Use when bleeding is directly linked to anticoagulant use. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutClotting Disorder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Clotting Disorder.
Documenting 'history of clots' without specifying thrombophilia
Impact
Clinical: May lead to inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Specify hereditary or acquired thrombophilia., Include genetic test results.
Coding DVT alone as thrombophilia
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate patient records.
Mitigation
Code I82.411 first, then D68.59 only if thrombophilia is documented.
Overcoding R79.1 for abnormal coagulation profile
Impact
Reimbursement: May result in claim rejections., Compliance: Violation of coding standards., Data Quality: Misleading clinical data.
Mitigation
Use only if no definitive coagulopathy exists.
Thrombophilia coding without genetic confirmation
Impact
High risk of audit if thrombophilia is coded without documented genetic confirmation.
Mitigation
Require genetic test documentation before coding.